Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?
Open Access
- 17 August 2015
- Vol. 7 (8), 6900-6923
- https://doi.org/10.3390/nu7085314
Abstract
It is widely recognized that the intestinal microbiota plays a role in the initiation and perpetuation of intestinal inflammation in numerous chronic conditions. Most studies report intestinal dysbiosis in celiac disease (CD) patients, untreated and treated with a gluten-free diet (GFD), compared to healthy controls. CD patients with gastrointestinal symptoms are also known to have a different microbiota compared to patients with dermatitis herpetiformis and controls, suggesting that the microbiota is involved in disease manifestation. Furthermore, a dysbiotic microbiota seems to be associated with persistent gastrointestinal symptoms in treated CD patients, suggesting its pathogenic implication in these particular cases. GFD per se influences gut microbiota composition, and thus constitutes an inevitable confounding factor in studies conducted in CD patients. To improve our understanding of whether intestinal dysbiosis is the cause or consequence of disease, prospective studies in healthy infants at family risk of CD are underway. These studies have revealed that the CD host genotype selects for the early colonizers of the infant’s gut, which together with environmental factors (e.g., breast-feeding, antibiotics, etc.) could influence the development of oral tolerance to gluten. Indeed, some CD genes and/or their altered expression play a role in bacterial colonization and sensing. In turn, intestinal dysbiosis could promote an abnormal response to gluten or other environmental CD-promoting factors (e.g., infections) in predisposed individuals. Here, we review the current knowledge of host-microbe interactions and how host genetics/epigenetics and environmental factors shape gut microbiota and may influence disease risk. We also summarize the current knowledge about the potential mechanisms of action of the intestinal microbiota and specific components that affect CD pathogenesis.Keywords
This publication has 122 references indexed in Scilit:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis PatientsPLOS ONE, 2013
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseasesSeminars in Immunopathology, 2012
- Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in miceThe ISME Journal, 2012
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for ColitisCell, 2011
- Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigensInflammatory Bowel Diseases, 2011
- Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseasesInflammatory Bowel Diseases, 2011
- A genetic perspective on coeliac diseaseTrends in Molecular Medicine, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- The molecular basis of NOD2 susceptibility mutations in Crohn's diseaseMucosal Immunology, 2008